Healthcare -
Biotechnology - NASDAQ - US
$ 0.7132
1.86 %
$ 36.9 M
Market Cap
-1.04
P/E
XLO - OPERATING INCOME
Operating Income XLO - Xilio Therapeutics, Inc.
-60.6 M
LAST VALUE
17.56%
2 YEAR CAGR
-26.07%
5 YEAR CAGR
0.00%
10 YEAR CAGR